加拿大批准了首款G7通用制药Ozempic，价格减半。 Canada approves first G7 generic Ozempic, cutting prices by half.

加拿大卫生部批准了第二种由加拿大的公司Apotex制造的糖尿病药Ozempic. Health Canada has approved a second generic version of the diabetes drug Ozempic, manufactured by the Canadian company Apotex. 这使加拿大成为第一个授权使用仿制药的G7国家. This makes Canada the first G7 nation to authorize generic alternatives to the drug. 现在有两种仿制药,预计价格将大幅下降至品牌成本的50%左右,为患者和医疗保健系统提供缓解. With two generics now available, pricing is expected to drop significantly to about 50% of the brand-name cost, offering relief to patients and the healthcare system.